Praxis Precision Medicines Inc.

06/12/2026 | Press release | Distributed by Public on 06/12/2026 14:46

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.
On June 10, 2026, Praxis Precision Medicines, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting"), at which a quorum was present. The Company held its Annual Meeting to consider and vote on the three proposals set forth below, each of which is described in greater detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 30, 2026. The final voting results are set forth below.
Proposal 1 - Election of Class III Directors
The Company's stockholders elected Gregory Norden, Marcio Souza and William Young to serve as Class III members of the Board of Directors of the Company until the Company's 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal, with the votes cast as follows:
Class III Director Nominees Votes For Votes Withheld Broker Non-Vote
Gregory Norden 24,597,327 310,937 1,815,967
Marcio Souza 24,771,396 136,868 1,815,967
William Young 21,293,535 3,614,729 1,815,967
Proposal 2 - Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm
The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast as follows:
Votes For Votes Against Abstain Broker Non-Vote
26,667,376 39,285 17,570 0
Proposal 3 - Advisory Vote on Executive Compensation
The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, with the votes cast as follows:
Votes For Votes Against Abstain Broker Non-Vote
24,054,017 824,318 29,929 1,815,967
No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting.
Praxis Precision Medicines Inc. published this content on June 12, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 12, 2026 at 20:47 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]